Holen Sie sich die Stockscreener-App
14.76
1.01%
-0.1458
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
4.15%
45.88
|
47.86 | 34.87 | 36.77 | 37.62 |
| Operating Income/Loss |
4.15%
-45.88
|
-47.86 | -34.87 | -36.77 | -37.62 |
| Nonoperating Income/Loss |
10.29%
3.66
|
4.08 | 4.484 | 3.201 | 3.066 |
| Income/Loss From Continuing Operations Before Tax |
3.58%
-42.22
|
-43.78 | -30.39 | -33.56 | -34.55 |
| Income/Loss From Continuing Operations After Tax |
3.58%
-42.22
|
-43.78 | -30.39 | -33.57 | -34.55 |
|
Net Income/Loss
|
3.58%
-42.22
|
-43.78 | -30.39 | -33.57 | -34.55 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.27%
85.73
|
85.50 | 85.43 | 5.5494 | 57.26 |
| Diluted Average Shares |
0.27%
85.73
|
85.50 | 85.43 | 5.5494 | 57.26 |
| Basic Earnings Per Share |
3.92%
-0.49
|
-0.51 | -0.36 | -0.40 | -0.60 |
| Diluted Earnings Per Share |
3.92%
-0.49
|
-0.51 | -0.36 | -0.40 | -0.60 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):